The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Human Gut Microbiota and Gastrointestinal Cancer
Open accessAbstract
Human gut microbiota play an essential role in both healthy and diseased states of humans. In the past decade, the interactions between microorganisms and tumors have attracted much attention in the efforts to understand various features of the complex microbial communities, as well as the possible mechanisms through which the microbiota are involved in cancer prevention, carcinogenesis, and anti-cancer therapy. A large number of studies have indicated that microbial dysbiosis contributes to cancer susceptibility via multiple pathways. Further studies have suggested that the microbiota and their associated metabolites are not only closely related to carcinogenesis by inducing inflammation and immune dysregulation, which lead to genetic instability, but also interfere with the pharmacodynamics of anticancer agents. In this article, we mainly reviewed the influence of gut microbiota on cancers in the gastrointestinal (GI) tract (including esophageal, gastric, colorectal, liver, and pancreatic cancers) and the regulation of microbiota by diet, prebiotics, probiotics, synbiotics, antibiotics, or the Traditional Chinese Medicine. We also proposed some new strategies in the prevention and treatment of GI cancers that could be explored in the future. We hope that this review could provide a comprehensive overview of the studies on the interactions between the gut microbiota and GI cancers, which are likely to yield translational opportunities to reduce cancer morbidity and mortality by improving prevention, diagnosis, and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 1×
“Moreover, tumor progression is almost prohibited after the treatment [234].”
BackgroundThe innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., & Aderem, A. (2001) · Nature · doi:10.1038/35074106 · Cited by 3,601
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,816
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179
How colonization by microbiota in early life shapes the immune system
Gensollen, T., Iyer, S. S., Kasper, D. L., & Blumberg, R. S. (2016) · Science · doi:10.1126/science.aad9378 · Cited by 2,044
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
The Essential Medicinal Chemistry of Curcumin
Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00975 · Cited by 1,956
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30143-7 · Cited by 1,635
Inferences, questions and possibilities in Toll-like receptor signalling
Beutler, B. (2004) · Nature · doi:10.1038/nature02761 · Cited by 1,466
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Bile acids and the gut microbiome
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329
Fungal microbiota dysbiosis in IBD
Sokol, H., Leducq, V., Aschard, H., Pham, H.-P., Jegou, S., Landman, C., Cohen, D., Liguori, G., Bourrier, A., Nion-Larmurier, I., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310746 · Cited by 1,314
Probiotics, prebiotics and synbiotics- a review
Pandey, K. R., Naik, S. R., & Vakil, B. V. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1921-1 · Cited by 1,291
Translocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Jakobsson, H. E., Jernberg, C., Andersson, A. F., Sjölund-Karlsson, M., Jansson, J. K., & Engstrand, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009836 · Cited by 1,160
Molecular analysis of the bacterial microbiota in the human stomach
Bik, E. M., Eckburg, P. B., Gill, S. R., Nelson, K. E., Purdom, E. A., Francois, F., Perez-Perez, G., Blaser, M. J., & Relman, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506655103 · Cited by 1,158
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310101 · Cited by 1,080
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
Microbial Ecology and Evolution: A Ribosomal RNA Approach
Olsen, G. J., Lane, D. J., Giovannoni, S. J., Pace, N. R., & Stahl, D. A. (1986) · Annual Review of Microbiology · doi:10.1146/annurev.mi.40.100186.002005 · Cited by 1,078
Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862
Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells
Cuevas-Ramos, G., Petit, C. R., Marcq, I., Boury, M., Oswald, E., & Nougayrède, J.-P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001261107 · Cited by 855
Gut microbiota imbalance and colorectal cancer
Gagnière, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.501 · Cited by 845
Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
Li, J., Sung, C. Y. J., Lee, N., Ni, Y., Pihlajamäki, J., Panagiotou, G., & El-Nezami, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518189113 · Cited by 626
Helicobacter exploits integrin for type IV secretion and kinase activation
Kwok, T., Zabler, D., Urman, S., Rohde, M., Hartig, R., Wessler, S., Misselwitz, R., Berger, J., Sewald, N., König, W., et al. (2007) · Nature · doi:10.1038/nature06187 · Cited by 619
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer
Couturier-Maillard, A., Secher, T., Rehman, A., Normand, S., De Arcangelis, A., Haesler, R., Huot, L., Grandjean, T., Bressenot, A., Delanoye-Crespin, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62236 · Cited by 572
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533
Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
Fukuda, A., Wang, S. C., Morris, J. P., Folias, A. E., Liou, A., Kim, G. E., Akira, S., Boucher, K. M., Firpo, M. A., Mulvihill, S. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.002 · Cited by 521
Yang, L., Lu, X., Nossa, C. W., Francois, F., Peek, R. M., & Pei, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.046 · Cited by 490
Huycke, M. M., Abrams, V., & Moore, D. R. (2002) · Carcinogenesis · doi:10.1093/carcin/23.3.529 · Cited by 489
Hussain, S. P., Amstad, P., Raja, K., Ambs, S., Nagashima, M., Bennett, W. P., Shields, P. G., Ham, A. L., Swenberg, J. A., Marrogi, A. J., et al. (2000) · PubMed · Cited by 482
Li, C.-W., Xia, W., Huo, L., Lim, S.-O., Wu, Y., Hsu, J. L., Chao, C.-H., Yamaguchi, H., Yang, N.-K., Ding, Q., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3123 · Cited by 467
Role of lipoteichoic acid in infection and inflammation
Ginsburg, I. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00226-8 · Cited by 425
Putoczki, T. L., Thiem, S., Loving, A., Busuttil, R. A., Wilson, N. J., Ziegler, P. K., Nguyen, P. M., Preaudet, A., Farid, R., Edwards, K. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.017 · Cited by 421
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas
Shen, X. J., Rawls, J. F., Randall, T. A., Burcall, L., Mpande, C., Jenkins, N., Jovov, B., Abdo, Z., Sandler, R. S., & Keku, T. O. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12360 · Cited by 418
Innate immune mechanisms of colitis and colitis-associated colorectal cancer
Saleh, M., & Trinchieri, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri2891 · Cited by 403
Mitsuhashi, K., Nosho, K., Sukawa, Y., Matsunaga, Y., Ito, M., Kurihara, H., Kanno, S., Igarashi, H., Naito, T., Adachi, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3109 · Cited by 402
Roles for KRAS in Pancreatic Tumor Development and Progression
di Magliano, M. P., & Logsdon, C. D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.071 · Cited by 400
Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation
Wu, S., Morin, P. J., Maouyo, D., & Sears, C. L. (2003) · Gastroenterology · doi:10.1053/gast.2003.50047 · Cited by 393
Cancer and infection: estimates of the attributable fraction in 1990.
Pisani, P., Parkin, D. M., Muñóz, N., & Ferlay, J. (1997) · PubMed · Cited by 388
Yu, L.-X., Yan, H.-X., Liu, Q., Yang, W., Wu, H.-P., Dong, W., Tang, L., Lin, Y., He, Y.-Q., Zou, S.-S., et al. (2010) · Hepatology · doi:10.1002/hep.23845 · Cited by 349
The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity
Lam, W., Bussom, S., Guan, F., Jiang, Z., Zhang, W., Gullen, E. A., Liu, S.-H., & Cheng, Y.-C. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001270 · Cited by 344
Assembly and function of a bacterial genotoxin
Nešić, D., Hsu, Y., & Stebbins, C. E. (2004) · Nature · doi:10.1038/nature02532 · Cited by 343
Aviles-Jimenez, F., Vazquez-Jimenez, F., Medrano-Guzman, R., Mantilla, A., & Torres, J. (2014) · Scientific Reports · doi:10.1038/srep04202 · Cited by 339
Gastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 322
Immune-microbiota interactions in health and disease
Palm, N. W., de Zoete, M. R., & Flavell, R. A. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.014 · Cited by 315
Ochi, A., Nguyen, A. H., Bedrosian, A. S., Mushlin, H. M., Zarbakhsh, S., Barilla, R., Zambirinis, C. P., Fallon, N. C., Rehman, A., Pylayeva-Gupta, Y., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111706 · Cited by 304
Structure of the human gastric bacterial community in relation to Helicobacter pylori status
Maldonado-Contreras, A., Goldfarb, K. C., Godoy-Vitorino, F., Karaoz, U., Contreras, M., Blaser, M. J., Brodie, E. L., & Dominguez-Bello, M. G. (2011) · The ISME Journal · doi:10.1038/ismej.2010.149 · Cited by 301
Cytokines, Inflammation and Colon Cancer
Klampfer, L. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795538066 · Cited by 289
Daniluk, J., Liu, Y., Deng, D., Chu, J., Huang, H., Gaiser, S., Cruz-Monserrate, Z., Wang, H., Ji, B., & Logsdon, C. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59743 · Cited by 276
Boursi, B., Mamtani, R., Haynes, K., & Yang, Y.-X. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.08.015 · Cited by 263
The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis
Chen, G. Y., Shaw, M. H., Redondo, G., & Núñez, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2061 · Cited by 261
Brown, D. G., Rao, S., Weir, T. L., O’Malia, J., Bazan, M., Brown, R. J., & Ryan, E. P. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0151-y · Cited by 254
Probiotics, prebiotics and colorectal cancer prevention
Ambalam, P., Raman, M., Purama, R. K., & Doble, M. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.009 · Cited by 251
Richards, J. L., Yap, Y. A., McLeod, K. H., Mackay, C. R., & Mariño, E. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.29 · Cited by 250
Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma
Runge, T. M., Abrams, J. A., & Shaheen, N. J. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.02.001 · Cited by 247
Wang, X., & Huycke, M. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.040 · Cited by 242
Fox, J. G., Feng, Y., Theve, E. J., Raczynski, A. R., Fiala, J. L. A., Doernte, A. L., Williams, M., McFaline, J. L., Essigmann, J. M., Schauer, D. B., et al. (2010) · Gut · doi:10.1136/gut.2009.183749 · Cited by 237
Yong, X., Tang, B., Li, B.-S., Xie, R., Hu, C.-J., Luo, G., Qin, Y., Dong, H., & Yang, S.-M. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0111-0 · Cited by 235
Nuñez-Sánchez, M. A., García-Villalba, R., Monedero-Saiz, T., García-Talavera, N. V., Gómez-Sánchez, M. B., Sánchez-Álvarez, C., García-Albert, A. M., Rodríguez-Gil, F. J., Ruiz-Marín, M., Pastor-Quirante, F. A., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300931 · Cited by 235
The gut microbiota in conventional and serrated precursors of colorectal cancer
Peters, B. A., Dominianni, C., Shapiro, J. A., Church, T. R., Wu, J., Miller, G., Yuen, E., Freiman, H., Lustbader, I., Salik, J., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0218-6 · Cited by 230
Gut microbiota and probiotics in colon tumorigenesis
Zhu, Y., Michelle Luo, T., Jobin, C., & Young, H. A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.004 · Cited by 229
The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention
McFadden, R.-M. T., Larmonier, C. B., Shehab, K. W., Midura-Kiela, M., Ramalingam, R., Harrison, C. A., Besselsen, D. G., Chase, J. H., Caporaso, J. G., Jobin, C., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000522 · Cited by 225
Analyses of Intestinal Microbiota: Culture versus Sequencing: Figure 1
Hiergeist, A., Gläsner, J., Reischl, U., & Gessner, A. (2015) · ILAR Journal · doi:10.1093/ilar/ilv017 · Cited by 213
Tebani, A., Afonso, C., Marret, S., & Bekri, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091555 · Cited by 212
Gianotti, L. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i2.167 · Cited by 209
Grąt, M., Wronka, K. M., Krasnodębski, M., Masior, Ł., Lewandowski, Z., Kosińska, I., Grąt, K., Stypułkowski, J., Rejowski, S., Wasilewicz, M., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.01.077 · Cited by 206
The immune network in pancreatic cancer development and progression
Wörmann, S. M., Diakopoulos, K. N., Lesina, M., & Algül, H. (2014) · Oncogene · doi:10.1038/onc.2013.257 · Cited by 205
The Contribution of Cytolethal Distending Toxin to Bacterial Pathogenesis
Smith, J. L., & Bayles, D. O. (2006) · Critical Reviews in Microbiology · doi:10.1080/10408410601023557 · Cited by 205
Extragastric Diseases and Helicobacter pylori
Franceschi, F., Gasbarrini, A., Polyzos, S. A., & Kountouras, J. (2015) · Helicobacter · doi:10.1111/hel.12256 · Cited by 204
Wu, S., Powell, J., Mathioudakis, N., Kane, S., Fernandez, E., & Sears, C. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5832-5839.2004 · Cited by 203
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
Ochi, A., Graffeo, C. S., Zambirinis, C. P., Rehman, A., Hackman, M., Fallon, N., Barilla, R. M., Henning, J. R., Jamal, M., Rao, R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63606 · Cited by 199
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Yu, J., Marsh, S., Hu, J., Feng, W., & Wu, C. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/2862173 · Cited by 199
Yang, L., Francois, F., & Pei, Z. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0934 · Cited by 192
Symbiotic Human Gut Bacteria with Variable Metabolic Priorities for Host Mucosal Glycans
Pudlo, N. A., Urs, K., Kumar, S. S., German, J. B., Mills, D. A., & Martens, E. C. (2015) · mBio · doi:10.1128/mbio.01282-15 · Cited by 187
Pattern recognition receptors: A contemporary view on liver diseases
Szabo, G., Dolganiuc, A., & Mandrekar, P. (2006) · Hepatology · doi:10.1002/hep.21308 · Cited by 183
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
Borena, W., Strohmaier, S., Lukanova, A., Bjørge, T., Lindkvist, B., Hallmans, G., Edlinger, M., Stocks, T., Nagel, G., Manjer, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26338 · Cited by 177
Amir, I., Konikoff, F. M., Oppenheim, M., Gophna, U., & Half, E. E. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12285 · Cited by 176
Sharif, R., Dawra, R., Wasiluk, K., Phillips, P., Dudeja, V, Kurt-Jones, E., Finberg, R., & Saluja, A. (2009) · Gut · doi:10.1136/gut.2008.170423 · Cited by 174
Helicobacter pylori and Extragastric Diseases
Franceschi, F., Tortora, A., Gasbarrini, G., & Gasbarrini, A. (2014) · Helicobacter · doi:10.1111/hel.12159 · Cited by 173
Jain, P., Luo, Z.-Q., & Blanke, S. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105175108 · Cited by 172
Pancreatic Cancer, Inflammation, and Microbiome
Zambirinis, C. P., Pushalkar, S., Saxena, D., & Miller, G. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000045 · Cited by 169
Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links
Jurjus, A. R., Eid, A., Kattar, S. A., Zeenny, M. N., Geagea, A. G., Haydar, H., Hilal, A., Oueidat, D., Matar, M., Tawilah, J., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.11.002 · Cited by 167
Payne, C. M., Weber, C., Crowley-Skillicorn, C., Dvorak, K., Bernstein, H., Bernstein, C., Holubec, H., Dvorakova, B., & Garewal, H. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl139 · Cited by 166
Oh, B., Kim, B., Kim, J. W., Kim, J. S., Koh, S., Kim, B. G., Lee, K. L., & Chun, J. (2016) · Helicobacter · doi:10.1111/hel.12270 · Cited by 164
Influence of Gut Microbiota on Subclinical Inflammation and Insulin Resistance
Carvalho, B. M., & Abdalla Saad, M. J. (2013) · Mediators of Inflammation · doi:10.1155/2013/986734 · Cited by 163
Kuugbee, E. D., Shang, X., Gamallat, Y., Bamba, D., Awadasseid, A., Suliman, M. A., Zang, S., Ma, Y., Chiwala, G., Xin, Y., et al. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4238-7 · Cited by 163
Metabolic syndrome and hepatocellular carcinoma risk
Turati, F., Talamini, R., Pelucchi, C., Polesel, J., Franceschi, S., Crispo, A., Izzo, F., La Vecchia, C., Boffetta, P., & Montella, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.492 · Cited by 161
Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats
Lin, X. B., Dieleman, L. A., Ketabi, A., Bibova, I., Sawyer, M. B., Xue, H., Field, C. J., Baracos, V. E., & Gänzle, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039764 · Cited by 159
Sharma, M., Li, L., Celver, J. P., Killian, C., Kovoor, A., & Seeram, N. P. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902857v · Cited by 158
Willhite, D. C., & Blanke, S. R. (2004) · Cellular Microbiology · doi:10.1046/j.1462-5822.2003.00347.x · Cited by 158
Helicobacter pylori infection and esophageal cancer risk: An updated meta-analysis
Xie, F.-J. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i36.6098 · Cited by 158
Wells, J. E., & Hylemon, P. B. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.3.1107-1113.2000 · Cited by 154
Epigenetic impact of infection on carcinogenesis: mechanisms and applications
Hattori, N., & Ushijima, T. (2016) · Genome Medicine · doi:10.1186/s13073-016-0267-2 · Cited by 152
Oncogenic K-Ras requires activation for enhanced activity
Huang, H., Daniluk, J., Liu, Y., Chu, J., Li, Z., Ji, B., & Logsdon, C. D. (2013) · Oncogene · doi:10.1038/onc.2012.619 · Cited by 145
Helicobacter species and liver diseases: association or causation?
Pellicano, R., Ménard, A., Rizzetto, M., & Mégraud, F. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70066-5 · Cited by 144
TLR4 signalling in the intestine in health and disease
Fukata, M., & Abreu, M. T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351473 · Cited by 144
CpG island hypermethylation in progression of esophageal and gastric cancer
Sato, F., & Meltzer, S. J. (2005) · Cancer · doi:10.1002/cncr.21657 · Cited by 143
Helicobacter pylori VacA-induced Inhibition of GSK3 through the PI3K/Akt Signaling Pathway
Nakayama, M., Hisatsune, J., Yamasaki, E., Isomoto, H., Kurazono, H., Hatakeyama, M., Azuma, T., Yamaoka, Y., Yahiro, K., Moss, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806981200 · Cited by 142
Ogino, S., Lochhead, P. J., Giovannucci, E. L., Meyerhardt, J. A., Fuchs, C. S., & Chan, A. T. (2013) · Oncogene · doi:10.1038/onc.2013.244 · Cited by 141
Immune responses toHelicobacter pyloriinfection
Moyat, M., & Velin, D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i19.5583 · Cited by 141
Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells
González‐Sarrías, A., Giménez‐Bastida, J. A., Núñez‐Sánchez, M. Á., Larrosa, M., García‐Conesa, M., Tomás-Barberán, F. A., & Espín, J. C. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0589-4 · Cited by 141
Asquith, M. J., & Powrie, F. M. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101330 · Cited by 141
Helicobacter pylori and extragastric diseases
Franceschi, F., & Gasbarrini, A. (2007) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.10.003 · Cited by 138
Winkels, R. M., Heine-Bröring, R. C., van Zutphen, M., van Harten-Gerritsen, S. A., Kok, D. E. G., van Duijnhoven, F. J., & Kampman, E. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-374 · Cited by 137
Costabile, A., Fava, F., Röytiö, H., Forssten, S. D., Olli, K., Klievink, J., Rowland, I. R., Ouwehand, A. C., Rastall, R. A., Gibson, G. R., et al. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511005782 · Cited by 135
Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions
Lara-Tejero, M., & Galán, J. E. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02316-8 · Cited by 135
Hermann, C., Spreitzer, I., Schröder, N. W. J., Morath, S., Lehner, M. D., Fischer, W., Schütt, C., Schumann, R. R., & Härtung, T. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2<541::aid-immu541>3.0.co;2-p · Cited by 132
An, J., & Ha, E.-M. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1605.05024 · Cited by 132
Chng, K. R., Chan, S. H., Ng, A. H. Q., Li, C., Jusakul, A., Bertrand, D., Wilm, A., Choo, S. P., Tan, D. M. Y., Lim, K. H., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.034 · Cited by 129
The Niacin/Butyrate Receptor GPR109A Suppresses Mammary Tumorigenesis by Inhibiting Cell Survival
Elangovan, S., Pathania, R., Ramachandran, S., Ananth, S., Padia, R. N., Lan, L., Singh, N., Martin, P. M., Hawthorn, L., Prasad, P. D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1451 · Cited by 128
A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide
Ding, S. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i3.584 · Cited by 127
KRAS mutations predict response to EGFR inhibitors
Raponi, M., Winkler, H. J. S., & Dracopoli, N. C. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.006 · Cited by 127
Motoori, M., Yano, M., Miyata, H., Sugimura, K., Saito, T., Omori, T., Fujiwara, Y., Miyoshi, N., Akita, H., Gotoh, K., et al. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.11.008 · Cited by 127
Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis
Zackular, J. P., Baxter, N. T., Chen, G., & Schloss, P. D. (2015) · mSphere · doi:10.1128/msphere.00001-15 · Cited by 127
Dismicrobism in inflammatory bowel disease and colorectal cancer: Changes in response of colocytes
Tomasello, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18121 · Cited by 126
Role of Helicobacter pylori in gastric cancer: Updates
Khatoon, J. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i2.147 · Cited by 126
Wnt/β-catenin, an oncogenic pathway targeted byH. pyloriin gastric carcinogenesis
Song, X., Xin, N., Wang, W., & Zhao, C. (2015) · Oncotarget · doi:10.18632/oncotarget.5758 · Cited by 122
Basset, C., Holton, J., Bazeos, A., Vaira, D., & Bloom, S. L. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000042241.13489.88 · Cited by 121
Microbiota, Oral Microbiome, and Pancreatic Cancer
Michaud, D. S., & Izard, J. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000046 · Cited by 119
González‐Sarrías, A., Tomé‐Carneiro, J., Bellesia, A., Tomás-Barberán, F. A., & Espı́n, J. C. (2015) · Food & Function · doi:10.1039/c5fo00120j · Cited by 119
Innate immune recognition of the indigenous microbial flora
Rakoff-Nahoum, S., & Medzhitov, R. M. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.49 · Cited by 117
Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation?
de Rycke, J., & Oswald, É. (2001) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00344-5 · Cited by 116
Doorakkers, E., Lagergren, J., Engstrand, L. G., & Brusselaers, N. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw132 · Cited by 113
Kummar, S., Copur, M. S., Rose, M. G., Wadler, S., Stephenson, J., O’Rourke, M. A., Brenckman, W. D., Tilton, R., Liu, S.-H., Jiang, Z., et al. (2011) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2011.03.003 · Cited by 111
Synthetic long-read sequencing reveals intraspecies diversity in the human microbiome
Kuleshov, V., Jiang, C., Zhou, W., Jahanbani, F., Batzoglou, S., & Snyder, M. P. (2015) · Nature Biotechnology · doi:10.1038/nbt.3416 · Cited by 110
Eid, N. M. S., Osmanova, H., Natchez, C., Walton, G., Costabile, A., Gibson, G. R., Rowland, I. R., & Spencer, J. P. E. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002780 · Cited by 105
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 103
Nepelska, M., Cultrone, A., Béguet-Crespel, F., Roux, K. L., Dore, J. M., Arulampalam, V., & Blottière, H. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052869 · Cited by 101
Dias-Jácome, E., Libânio, D., Borges‐Canha, M., Galaghar, A., & Pimentel‐Nunes, P. (2016) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2016.4261/2016 · Cited by 100
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
Wong, C. R., Nguyen, M. H., & Lim, J. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i37.8294 · Cited by 100
A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis
Kountouras, J., Zavos, C., & Chatzopoulos, D. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00349.x · Cited by 99
Higashimura, Y., Naito, Y., Takagi, T., Uchiyama, K., Mizushima, K., Ushiroda, C., Ohnogi, H., Kudo, Y., Yasui, M., Inui, S., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00324.2015 · Cited by 99
Nasrollahzadeh, D., Malekzadeh, R., Ploner, A., Shakeri, R., Sotoudeh, M., Fahimi, S., Nasseri‐Moghaddam, S., Kamangar, F., Abnet, C. C., Winckler, B., et al. (2015) · Scientific Reports · doi:10.1038/srep08820 · Cited by 96
Piazzi, G., D’Argenio, G., Prossomariti, A., Lembo, V., Mazzone, G., Candela, M., Biagi, E., Brigidi, P., Vitaglione, P., Fogliano, V., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28853 · Cited by 96
Shields, C. E. D., Meerbeke, S. W. V., Housseau, F., Wang, H., Huso, D. L., Casero, R. A., O’Hagan, H. M., & Sears, C. L. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw069 · Cited by 96
Wnt signaling inside the nucleus
Shitashige, M., Hirohashi, S., & Yamada, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00716.x · Cited by 95
Kostovcikova, K., Kverka, M., Zakostelska, Z. J., Hudcovic, T., Hrnčíř, T., Štëpánková, R., Rossmann, P., Rídl, J., Kostovčík, M., Mrázek, J., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281330a · Cited by 95
Gaida, M. M., Mayer, C., Dapunt, U., Stegmaier, S., Schirmacher, P., Wabnitz, G. H., & Hänsch, G. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7206 · Cited by 95
Zhang, M., Fan, X., Fang, B., Zhu, C., Zhu, J., & Ren, F. (2015) · The Journal of Microbiology · doi:10.1007/s12275-015-5046-z · Cited by 91
Hu, Q., Sun, T.-T., Hong, J., Fang, J., Xiong, H., & Meltzer, S. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169691 · Cited by 89
Helicobacter pylori and extragastric diseases
Goni, E., & Franceschi, F. (2016) · Helicobacter · doi:10.1111/hel.12340 · Cited by 88
Flagellin: key target of mucosal innate immunity
Vijay–Kumar, M., & Gewirtz, A. T. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.9 · Cited by 87
Chandrakesan, P., Roy, B. C., Jakkula, L. U. M. R., Ahmed, I., Ramamoorthy, P., Tawfik, O. W., Papineni, R. V. L., Houchen, C. W., Anant, S., & Umar, S. (2013) · Oncogene · doi:10.1038/onc.2013.210 · Cited by 85
Wang, P., Chen, H., Zhu, Y., McBride, J. E., Fu, J., & Sang, S. (2014) · Journal of Nutrition · doi:10.3945/jn.114.206508 · Cited by 85
Extragastric Diseases and H elicobacter pylori
Baudron, C. R., Franceschi, F., Salles, N., & Gasbarrini, A. (2013) · Helicobacter · doi:10.1111/hel.12077 · Cited by 83
Liu, N., Zhou, N., Chai, N., Liu, X., Jiang, H., Wu, Q., & Li, Q. (2016) · BMC Cancer · doi:10.1186/s12885-016-2351-9 · Cited by 82
Yamtich, J., Nemec, A. A., Keh, A., & Sweasy, J. B. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003052 · Cited by 81
Regulation of Wnt Signaling by the Nuclear Pore Complex
Shitashige, M., Satow, R., Honda, K., Ono, M., Hirohashi, S., & Yamada, T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.010 · Cited by 81
Caputo, R., Tuccillo, C., Manzo, B. A., Zarrilli, R., Tortora, G., Blanco, C. D. V., Ricci, V., Ciardiello, F., & Romano, M. (2003) · PubMed · Cited by 81
NOD-like receptors in intestinal homeostasis and epithelial tissue repair
Parlato, M., & Yeretssian, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069594 · Cited by 79
Ohtani, N. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0457-1 · Cited by 79
Gonçalves, E. M. A. R. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i30.2968 · Cited by 79
Miene, C., Weise, A., & Glei, M. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.552157 · Cited by 78
Su, S., Hua, K., Lee, H., Chao, L. K., Tan, S.-K., Lee, H., Yang, S., & Hsu, H. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.05.045 · Cited by 78
Brevik, A., Joshi, A. D., Corral, R., Onland‐Moret, N. C., Siegmund, K. D., Marchand, L. L., Baron, J. A., Martı́nez, M. E., Haile, R. W., Ahnen, D. J., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0606 · Cited by 77
Wang, E., Bussom, S., Chen, J., Quinn, C., Bedognetti, D., Lam, W., Guan, F., Jiang, Z., Mark, Y., Zhao, Y., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-38 · Cited by 74
Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors
Mladinich, M. C., Ruan, D., & Chan, C. (2016) · Stem Cells International · doi:10.1155/2016/5285892 · Cited by 71
Power, K. A., Lepp, D., Zarepoor, L., Monk, J. M., Wu, W., Tsao, R., & Liu, R. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.09.028 · Cited by 70
Zhou, D., Wang, J., Weng, M., Zhang, Y., Wang, X., Gong, W., & Quan, Z. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835c0362 · Cited by 69
Gopal, U., Jayanthi, V., Devaraj, N., & Devaraj, H. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20311 · Cited by 68
Alam, M. S., Gaida, M. M., Bergmann, F., Lasitschka, F., Giese, T., Giese, N. A., Hackert, T., Hinz, U., Hussain, S. P., Козлов, С. В., et al. (2015) · Nature Medicine · doi:10.1038/nm.3957 · Cited by 68
LPS receptor subunits have antagonistic roles in epithelial apoptosis and colonic carcinogenesis
Kuo, W.-T., Lee, T.-C., Yang, H., Chen, C.-Y., Au, Y.-C., Lu, Y., Wu, L., Wei, S.-C., Ni, Y., Lin, B.-R., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.240 · Cited by 66
Do biofilms confer a pro-carcinogenic state?
Dejea, C. M., & Sears, C. L. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1121363 · Cited by 65
Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota
Ericsson, A. C., Akter, S., Hanson, M. M., Busi, S. B., Parker, T. W., Schehr, R., Hankins, M. A., Ahner, C. E., Davis, J. W., Franklin, C. L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5604 · Cited by 64
Ricci, V. (2016) · Toxins · doi:10.3390/toxins8070203 · Cited by 64
Farrell, M. P., & Kummar, S. (2003) · Clinical Colorectal Cancer · doi:10.3816/ccc.2003.n.007 · Cited by 63
Modulation of Colon Cancer by Nutmeg
Li, F., Yang, X.-W., Krausz, K. W., Nichols, R. G., Xu, W., Patterson, A. D., & Gonzalez, F. J. (2015) · Journal of Proteome Research · doi:10.1021/pr5013152 · Cited by 62
Carino, A., Graziosi, L., D’Amore, C., Cipriani, S., Marchianò, S., Marino, E., Zampella, A., Rende, M., Mosci, P., Distrutti, E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10477 · Cited by 62
Yahiro, K., Akazawa, Y., Nakano, M., Suzuki, H., Hisatune, J., Isomoto, H., Sap, J., Noda, M., Moss, J., & Hirayama, T. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.35 · Cited by 62
Tsuneyama, K., Harada, K., Kono, N., Hiramatsu, K., Zen, Y., Sudo, Y., Gershwin, M. E., Ikemoto, M., Arai, H., & Nakanuma, Y. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00084-8 · Cited by 61
Chemoprevention in Gastrointestinal Physiology and Disease. Natural products and microbiome
Greiner, A. K., Papineni, R. V. L., & Umar, S. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00044.2014 · Cited by 60
Schinzari, V., Barnaba, V., & Piconese, S. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.026 · Cited by 54
Coleman, O. I., & Nunes, T. (2016) · BioResearch open access · doi:10.1089/biores.2016.0028 · Cited by 54
Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma
Neto, A. G., Whitaker, A., & Pei, Z. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.005 · Cited by 53
Queiroz, D. M. M., Rocha, A. M. C., Rocha, G. A., Cinque, S., de Oliveira, A. G., Godoy, A., & Tanno, H. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-3150-y · Cited by 51
Kim, J. M., Lee, J., Yoon, Y. M., Oh, Y., Kang, J., Kim, Y., & Kim, K. (2006) · European Journal of Immunology · doi:10.1002/eji.200535808 · Cited by 51
Epigenetic events in liver cancer resulting from alcoholic liver disease
French, S. W. (2013) · Alcohol research · doi:10.35946/arcr.v35.1.07 · Cited by 50
Viruses, Other Pathogenic Microorganisms and Esophageal Cancer
Xu, W., Liu, Z., Bao, Q., & Qian, Z. (2015) · Gastrointestinal Tumors · doi:10.1159/000380897 · Cited by 50
Cited by
Terpou, A., Papadaki, A., Lappa, I., Kachrimanidou, V., Bosnea, L., & Kopsahelis, N. (2019) · Nutrients · doi:10.3390/nu11071591 · Cited by 779
Gut microbiome and its role in colorectal cancer
Rebersek, M. (2021) · BMC Cancer · doi:10.1186/s12885-021-09054-2 · Cited by 355
Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment
Zhao, Z., & Liu, W. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820962117 · Cited by 348
Gut bacteria signaling to mitochondria in intestinal inflammation and cancer
Jackson, D. N., & Theiss, A. L. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1592421 · Cited by 312
Specific Gut Microbiome Signature Predicts the Early-Stage Lung Cancer
Zheng, Y., Fang, Z., Xue, Y., Zhang, J., Zhu, J., Gao, R., Yao, S., Ye, Y., Wang, S., Lin, C., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1737487 · Cited by 301
Metadata
- Authors
- Meng, C., Bai, C., Brown, T. D., Hood, L. E., & Tian, Q.
- Venue
- Genomics, Proteomics & Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-02-01
- Volume
- 16
- Issue
- 1
- Pages
- 33-49
- ISSN
- 1672-0229 (ISSN-L)
- 2210-3244
- OpenAlex
- W2793543050
- Cited by
- 467
- References
- 229
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.